Hospira Logo (Bleomycin 01)
Bleomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 61703-332
7 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 61703-332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula Bleomycin (Bleomycin 02)
Chemical structure diagram of the active ingredient Bleomycin showing its detailed molecular composition with labeled substituents A2 and B2. The structure includes ring systems, side chains, and atomic connectivity relevant to Bleomycin's chemical identity.*
Hospira Logo (Bleomycin 03)
Principal Display Panel (15 unit Vial Label)
Bleomycin for Injection, USP 30 units per vial, powder for injection. Single-dose vial labeled for intravenous, intramuscular, subcutaneous, and intrapleural use. The label includes a cytotoxicity warning and special handling instructions. Manufacturer is Hospira, Inc., with storage instructions between 2° to 8°C.*
Carton Ndc 61703-332-18 (Bleomycin 05)
The label for Bleomycin for Injection, USP from Hospira, Inc. displays a vial containing 30 units per vial of sterile powder for injection. It is a single-dose vial indicated for intravenous, intramuscular, subcutaneous, and intrapleural use. The label notes the product is lyophilized and must be diluted, with storage instructions to keep the powder refrigerated at 2°-8°C (36°-46°F). Several cautions about cytotoxic handling procedures are highlighted in a red band across the bottom of the label.*
Principal Display Panel (30 unit Vial Label)
Bleomycin for Injection, USP 15 units per vial, lyophilized powder for solution, in a single-dose vial. Label indicates administration routes: intravenous, intramuscular, subcutaneous, and intrapleural. The label includes cautions for cytotoxic handling and storage instructions to refrigerate at 2° to 8°C (36° to 46°F). Distributed by Hospira, Inc., Lake Forest, IL.*
Carton Ndc 61703-323-22 (Bleomycin 07)
Packaging label for Bleomycin for Injection, USP, 15 units per vial, lyophilized powder for solution. The label indicates a single-dose vial, sterile, for intravenous, intramuscular, subcutaneous, and intrapleural use. Manufactured by Hospira, Inc. The label includes storage instructions, warnings, and a caution about cytotoxicity and special handling procedures.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
